Sort
16,300 grants matching “fatty liver disease”
Dietary Fructose and Redox Effects in Pediatric Nonalcoholic Fatty Liver Disease
$174,139Miriam B. Vos · Emory University · K23 · FY2008 · DK
Dietary Fructose and Redox Effects in Pediatric Nonalcoholic Fatty Liver Disease
$174,139Miriam B. Vos · Emory University · K23 · FY2011 · DK
Dietary Fructose and Redox Effects in Pediatric Nonalcoholic Fatty Liver Disease
$174,139Miriam B. Vos · Emory University · K23 · FY2010 · DK
Dietary Fructose and Redox Effects in Pediatric Nonalcoholic Fatty Liver Disease
$174,139Miriam B. Vos · Emory University · K23 · FY2009 · DK
Improving the Diagnosis of Liver Disease in Primary Care Patients with Abnormal Liver Function
$174,108Andrew David Schreiner · Medical University Of South Carolina · K23 · FY2018 · DK
A METABOLIC BIOMARKER OF HEPATIC NADH/NAD+ RATIO
$174,100Russell Paul Goodman · Massachusetts General Hospital · K08 · FY2018 · DK
Mechanisms of Probiotics in Alcoholic Liver Disease
$173,756Wenke Feng · University Of Louisville · P20 · FY2019 · GM
UT GASTROENTEROLOGY/HEPATOLOGY RESEARCH TRAINING PROGRAM
$173,739John M. Dietschy · Ut Southwestern Medical Center · T32 · FY2007 · DK
Molecular and Cellular Analytical Core
$173,681Jacob E Friedman · University Of Colorado Denver · P30 · FY2019 · DK
Improving the Diagnosis of Liver Disease in Primary Care Patients with Abnormal Liver Function
$173,604Andrew David Schreiner · Medical University Of South Carolina · K23 · FY2019 · DK
Admin Core
$173,575Hashem B El-Serag · Baylor College Of Medicine · P01 · FY2025 · CA
Synergy of lipolysis and lipophagy in alcoholic liver disease
$173,556Micah Schott · Mayo Clinic Rochester · K99 · FY2019 · AA
Synergy of lipolysis and lipophagy in alcoholic liver disease
$173,556Micah Schott · Mayo Clinic Rochester · K99 · FY2020 · AA
Circadian regulation of molecular and systemic adipose tissue function in humans
$173,523Kelli Anne Lytle · Mayo Clinic Rochester · K01 · FY2024 · DK
Exogenous ketones target geroscience pathways and ameliorate geriatric syndromes
$173,403Brianna Jane Stubbs · Buck Institute For Research On Aging · K01 · FY2022 · AG
Endocrinology and Metabolism Core
$173,396Peter J Havel · University Of California At Davis · U2C · FY2017 · DK
Endocrinology and Metabolism Core
$173,396Peter J Havel · University Of California At Davis · U2C · FY2019 · DK
Endocrinology and Metabolism Core
$173,396Peter J Havel · University Of California At Davis · U2C · FY2020 · DK
Endocrinology and Metabolism Core
$173,396Peter J Havel · University Of California At Davis · U2C · FY2016 · DK
Dietary Fructose and Redox Effects in Pediatric Nonalcoholic Fatty Liver Disease
$173,394Miriam B. Vos · Emory University · K23 · FY2012 · DK
Healthy Aging and Myostatin Antagonsits
$173,225Wen Guo · Boston Medical Center · R21 · FY2012 · AG
In Vitro Liver Models to Investigate the Progression of Liver Fibrosis
$173,221Srivatsan Kidambi · University Of Nebraska Lincoln · P20 · FY2017 · GM
Developing a predictive understanding of harmful cyanbacteria growth, toxins production and comparative toxicity across environmentally important gradients of n:p and salinity
$173,151Bryan William Brooks · University Of South Carolina At Columbia · P01 · FY2022 · ES
Developing a predictive understanding of harmful cyanbacteria growth, toxins production and comparative toxicity across environmentally important gradients of n:p and salinity
$173,070Bryan William Brooks · University Of South Carolina At Columbia · P01 · FY2021 · ES
Improving the Diagnosis of Liver Disease in Primary Care Patients with Abnormal Liver Function
$173,047Andrew David Schreiner · Medical University Of South Carolina · K23 · FY2020 · DK